Source: International Congress 2014 – Ceremony for the ERS Best Publication Maurizio Vignola Award for Innovation in Pneumology 2014 - Clinical Year in Review II
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Huerta Garcia (Barcelona, Spain). Updates in pneumonia in patients with COPD. International Congress 2014 – Ceremony for the ERS Best Publication Maurizio Vignola Award for Innovation in Pneumology 2014 - Clinical Year in Review II

Member's Comments

No comment yet.

Related content which might interest you: Heliox-therapy of patients with execerbation of COPD and community-acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 106s Year: 2006 How can I differentiate community-acquired pneumonia (CAP)+COPD patients from acute exacerbation of COPD (AECOPD) patients? Source: International Congress 2015 – Differentiating COPD exacerbations from pneumonia in COPD patients Year: 2015 Validity of the diagnosis of pneumonia in hospitalised patients with COPD Source: ERJ Open Res, 5 (2) 00031-2019; 10.1183/23120541.00031-2019 Year: 2019 Impact of bronchiectasis on duration of hospitalization in patients with exacerbations of COPD Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015 COPD and pneumonia Source: International Congress 2015 – Different data in COPD Year: 2015 Survival in COPD patients with hospitalization due to exacerbation Source: International Congress 2014 – Longitudinal studies of respiratory disease Year: 2014 Neutrophil CD 64 expression as a diagnostic marker of pneumonia in patients with acute COPD exacerbation Source: International Congress 2014 – Markers Year: 2014 Severity and outcomes of hospitalised community-acquired pneumonia in COPD patients Source: Eur Respir J 2012; 39: 855-861 Year: 2012 Risk factors for another hospitalization in COPD patients hospitalized for exacerbation Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Pneumonia risk in COPD patients on long term inhaled corticosteroids – Data from the European COPD audit<% Source: Annual Congress 2013 –Guidelines and exacerbations Year: 2013 Characterization of readmissions in patients hospitalized with COPD exacerbation Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Characterising patterns of prescribing for UK COPD patients with comorbidities or history of pneumonia Source: International Congress 2014 – COPD exacerbations Year: 2014 Distinguishing features of pneumonia and exacerbations in COPD Source: International Congress 2015 – Prognostic factors in pneumonia: from clinical observations to experimental models Year: 2015 Influence of bronchiectasis in patients hospitalized due to acute exacerbation of COPD. Source: International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes Year: 2017 Analysis of therapy of community-acquired pneumonia (CAP) at the COPD patients Source: Annual Congress 2011 - COPD management Year: 2011 The impact of bronchiectasis on outcomes in a large cohort of patients hospitalised with exacerbations of COPD Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients Year: 2013 Mortality in patients with COPD due to community acquired pneumonia Source: Annual Congress 2007 - Severity scores and comorbidities in community-acquired pneumonia Year: 2007 Impact of frequent exacerbations in patients with COPD Source: International Congress 2014 – Clinical presentations Year: 2014 Seasonal variation in COPD admissions and pneumonia and a review of imaging follow up in these patients Source: Annual Congress 2013 –Pneumonia and sepsis Year: 2013 Role of comorbidities on mortality in patients hospitalized for COPD exacerbations Source: International Congress 2014 – The assessment of comorbidities Year: 2014